Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Operating Income (2013 - 2026)

Scienture Holdings' (SCNX) quarterly Operating Income came in at -$2.7 million in Q2 2026, up 47.66% year-over-year from -$1.8 million in Q2 2025, and up 23.07% quarter-over-quarter from -$3.5 million in Q1 2026.

Analysis

Scienture Holdings (SCNX) Operating Income (2013 - 2026) Analysis & Trends

Scienture Holdings has disclosed Operating Income across 14 years of filings, most recently posting -$2.7 million for Q2 2026.

  • In Q2 2026, Operating Income rose 47.66% year-over-year to -$2.7 million; the TTM figure through Jun 2026 stood at -$14.9 million (up 4.96% YoY), while the FY2025 annual figure was -$42.6 million, down 189.71% from the prior year.
  • Operating Income came in at -$2.7 million for Q2 2026 at Scienture Holdings, up from -$3.5 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$218763.0 in Q3 2022 to a low of -$5.5 million in Q1 2024.
  • Average Operating Income over 5 years is -$2.3 million, with a median of -$2.0 million recorded in 2022.
  • Year-over-year, Operating Income surged 83.12% in 2022 and plunged 581.43% in 2024.
  • Over 5 years, Operating Income stood at -$2.6 million in 2022, then dropped by 29.38% to -$3.3 million in 2023, then jumped by 55.03% to -$1.5 million in 2024, then plunged by 244.85% to -$5.2 million in 2025, then soared by 47.66% to -$2.7 million in 2026.
  • Per Business Quant data, the three most recent Operating Income figures were -$2.7 million in Q2 2026, -$3.5 million in Q1 2026, and -$5.2 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn -231.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 6.30 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 39.97 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 129.77 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 740.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 40.46 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -73.42 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 39.73 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 1.74 Mn
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00 -2.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.70 Mn
Mar 31, 2026 -3.51 Mn
Jun 30, 2025 -5.16 Mn
Mar 31, 2025 -3.57 Mn
Jun 30, 2024 -1.50 Mn
Mar 31, 2024 -5.49 Mn
Dec 31, 2023 -3.33 Mn
Sep 30, 2023 -845,149.00
Jun 30, 2023 -599,782.00
Mar 31, 2023 -806,090.00
Dec 31, 2022 -2.57 Mn
Sep 30, 2022 -218,763.00
Jun 30, 2022 -1.10 Mn
Mar 31, 2022 -968,572.00
Dec 31, 2021 -782,324.00
Sep 30, 2021 -1.30 Mn
Jun 30, 2021 -2.57 Mn
Mar 31, 2021 -644,255.00
Dec 31, 2020 -2.31 Mn
Sep 30, 2020 145,821.00